Delivery Order SPE2DR25D1202-SPE2DR26F72KF
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sevoflurane Inhalation Liquid in 250mL quantities, with a ceiling value of $4,649.76. This firm fixed price delivery order, issued on August 28, 2025, represents a non-competitive set-aside award and is scheduled for ultimate completion by August 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,278.08 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250 milliliter quantities. This competitively awarded contract, which carries no set-aside designation, is firm fixed price in nature and specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. The award was issued on September 5, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,713.60 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The award was made to support federal medical procurement needs, with the place of performance located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a contract ceiling value of $1,414.08. This award, issued on September 15, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively without a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $3,009.44. This was a firm fixed price contract awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The award represents a non-set-aside, competitively awarded procurement with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,775.04 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sevoflurane is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, valued at $2,565.14. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is due for completion by September 9, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sevoflurane Inhalation Liquid 250ML under a firm fixed-price contract with a ceiling value of $7,802.86. The contract, awarded on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $1,369.02. The contract was awarded on November 20, 2025, with an ultimate completion date of November 21, 2025, and operates under firm fixed-price terms with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,885.44 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250mL quantities. This contract was competitively awarded without set-aside provisions and operates under a firm fixed-price arrangement, with an ultimate completion date of August 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72KFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $1,102.80. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025, under a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in the same municipality. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. Sevoflurane, a volatile anesthetic commonly used in surgical procedures, aligns with the company's extensive portfolio of pharmaceutical products delivered to the Defense Health Agency and other federal healthcare entities through competitively awarded, non-set-aside contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/20/25 |